FDA OK of 1st 'Biosimilar' Drug May Mean Cheaper Options for Patients

March 6, 2015 7:00 PM

13 0

FRIDAY, March 6, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the nation's first "biosimilar" drug, a move that could lead to more affordable medications for Americans who take cutting-edge biologic drugs.

This first drug, Zarxio, is considered by the FDA to be a strong stand-in for a cancer drug called Neupogen, which was originally approved in 1991.

Also read: Hospitals Plan to Produce Generic Drugs in Bid to Fix Troubled Market

Read more

To category page